Apellis Pharmaceuticals, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC APLS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

644,445

Value ($000)

16,188

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	16,188	0.0%	644,445	12/31/2025
2025 Q3	11/10/2025	14,643	0.0%	647,082	9/30/2025
2025 Q2	8/12/2025	17,122	0.0%	989,143	6/30/2025
2025 Q1	9/15/2025	21,094	0.0%	964,499	3/31/2025
2024 Q4	2/6/2025	31,806	0.0%	996,748	12/31/2024
2024 Q3	11/12/2024	27,581	0.0%	956,362	9/30/2024
2024 Q2	8/12/2024	36,328	0.0%	947,034	6/30/2024
2024 Q1	5/9/2024	54,346	0.0%	924,562	3/31/2024
2023 Q4	2/6/2024	54,138	0.0%	904,409	12/31/2023
2023 Q3	11/8/2023	33,451	0.0%	879,357	9/30/2023
2023 Q2	8/10/2023	75,478	0.0%	828,522	6/30/2023
2023 Q1	5/12/2023	64,872	0.0%	983,509	3/31/2023
2022 Q4	2/13/2023	50,827	0.0%	982,927	12/31/2022
2022 Q3	11/14/2022	64,801	0.0%	948,759	9/30/2022
2022 Q2	8/15/2022	30,678	0.0%	678,401	6/30/2022
2022 Q1	5/13/2022	33,297	0.0%	655,308	3/31/2022
2021 Q4	2/11/2022	27,986	0.0%	591,914	12/31/2021
2021 Q3	11/16/2021	17,100	0.0%	518,811	9/30/2021
2021 Q2	8/16/2021	26,460	0.0%	418,666	6/30/2021
2021 Q1	5/17/2021	17,342	0.0%	404,127	3/31/2021
2020 Q4	2/16/2021	21,479	0.0%	375,499	12/31/2020
2020 Q3	11/13/2020	11,146	0.0%	369,428	9/30/2020
2020 Q2	8/20/2020	11,833	0.0%	362,289	6/30/2020
2020 Q1	5/15/2020	8,870	0.0%	331,083	3/31/2020
2019 Q4	2/7/2020	8,250	0.0%	269,413	12/31/2019